Boehringer and Sarah Cannon team for immune-oncology venturePartnership will seek to develop two immune checkpoint inhibitor candidates. Share XBoehringer and Sarah Cannon team for immune-oncology venturehttps://pharmaphorum.com/news/boehringer-sarah-cannon-team-immune-oncology-venture/